| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/14/2005 | US20050155104 Toxin complex proteins and genes from Xenorhabus bovienii |
| 07/14/2005 | US20050155103 Transgenic plants expressing lepidopteran-active delta-endotoxins |
| 07/14/2005 | US20050155098 Expression vector comprising reporter gene for as tool to establish stable supply of fluorescent fish with desired transgenes; bioreactor for heterologous gene expression |
| 07/14/2005 | US20050155097 Recombinant rodents comprising expression vector coding a toxin and somatotropin for use as tools in the study of pathologies and treatments relating to tissues and organ systems that typically contain eosinophils |
| 07/14/2005 | US20050155096 Expression vector comprising nucleotide sequences granulocyte colony stimulating factor for use as tool in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/14/2005 | US20050155094 Expression vector comprising nucleotide sequences coding human recombination activating protein (RAG-1) gene for use as tool in generating immunodeficient pigs; animal models and immunotherapy |
| 07/14/2005 | US20050155093 Using embryo transfer to generate modified animal model; tissue engineering; bioreactor for heterologous protein expression |
| 07/14/2005 | US20050155092 Mutant muscle protein nucleotide sequences for use in generating animal models for diagnosis and treatment of cardiovascular disorders |
| 07/14/2005 | US20050155090 Recombinant monoclonal antibody for use in prevention and treatment of cell proliferative disorders; antiproliferative agents; immunotherapy |
| 07/14/2005 | US20050155089 Transport protein for use in identifying modulators for prevention and treatment of inflammation, cardiovascular, neurological, reproductive and developmental disorders |
| 07/14/2005 | US20050154538 Crystal structure of the 30S ribosome and its use |
| 07/14/2005 | US20050154197 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/14/2005 | US20050154193 Immunoglobulin for use in diagnosis, prevention and treatment of infection, neurodegenerative, inflammatory and autoimmune disorders; immunotherapy |
| 07/14/2005 | US20050154191 Cat immunisation vectors |
| 07/14/2005 | US20050154190 compounds obtained by the screening of the present invention are useful as agents for the prevention/treatment of, for example, neurodegenerative diseases, immunological diseases, edema, acid indigestion, etc. |
| 07/14/2005 | US20050154189 Receptor polypeptide for use as immunomodulator in enhancement of immune response; immunotherapy |
| 07/14/2005 | US20050154187 Especially fused to dihydrofolate reductase, used for treating diseases marked by increased angiogenesis; also polynucleotides encoding the polypeptide and use of the polynucleotides in gene therapy. |
| 07/14/2005 | US20050153922 MutS homolog 5 (MSH5); gene expression inhibition; for modulation of fertility |
| 07/14/2005 | US20050153917 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 07/14/2005 | US20050153901 Of EtO2C CH2 (R)Cgl-Aze-Pab-OH or its salt; high chemical and solid state stability; thrombin inhibitors |
| 07/14/2005 | US20050153898 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 07/14/2005 | US20050153897 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 07/14/2005 | US20050153896 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 07/14/2005 | US20050153895 Laminin polypeptide biodrugs; inhibitors of A beta fibril formation and growth in brain |
| 07/14/2005 | US20050153891 proteins coded by murine herpes viruses, or homologues, use in binding chemokines, to produce an immunomodulatory or antiinflammatory effects |
| 07/14/2005 | US20050153890 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/14/2005 | US20050153888 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/14/2005 | US20050153886 nucleotide sequences comprising cDNA and genomic DNA that code for angiogenesis factors, used for gene therapy |
| 07/14/2005 | US20050153882 Polypeptides as angiogenesis inhibitors |
| 07/14/2005 | US20050153881 Produced by a lactic acid producing bacterial strain having the identifying characteristics of a strain selected from NRRL B-30514, NRRL B-30510, NRRL B-30511, and NRRL B-30645; used for reducing levels of colonization by a target bacteria in animals, especially poultry |
| 07/14/2005 | US20050153879 Process for the preparation of a desired erythropoietin glyco-isoform profile |
| 07/14/2005 | US20050153878 Fgfr agonists |
| 07/14/2005 | US20050153875 Has an iron binding capacity of at least 1.0 mg-per gram of protein, is non-pyrogenic and is pathogen free; preparation by anion exchange chromatography |
| 07/14/2005 | US20050153872 Polypeptide comprising an organism targeting agent such as a pheromone covalently attached to a channel forming moiety such as hemolysin, diphtheria toxin, delta toxin, anthrax toxin, and colicin to treat bacteria, fungi, or viral infections |
| 07/14/2005 | US20050153415 Lysin for use as tool in prevention of clostridial infection |
| 07/14/2005 | US20050153414 Regulator of G-protein signaling (RGS) polypeptide for use as tools in identifying modulators of cell signaling; antitumor agents; mimetics |
| 07/14/2005 | US20050153403 Process for preparing L-amino acids using strains of the enterobacteriaceae family |
| 07/14/2005 | US20050153402 Expression vector comprising nucleotide sequences coding metabolic regulatory (MR) proteins for use as tools which enhance exogenous gene expression; bioreactors; target construct for use in enhancing gene delivery to cells |
| 07/14/2005 | US20050153400 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 07/14/2005 | US20050153399 Introducing a DNA construct into a filamentous fungal cell, culturing the filamentous fungal cell under suitable culture conditions to allow expression of the heterologous DNA sequence, and producing the protease inhibitor |
| 07/14/2005 | US20050153396 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/14/2005 | US20050153395 Unique integrin binding site in connective tissue growth factor (CTGF) |
| 07/14/2005 | US20050153394 Targeting construct for use as tool in enhanced transfer gene sequences into cells; bioreactors; improving exogenous gene expression |
| 07/14/2005 | US20050153393 Chimeric protein fusion comprising signal peptides and non-polar carboxy tail; improvng stability of proteins; directed protein evolution |
| 07/14/2005 | US20050153391 Polypeptides capable of binding to G protein coupled receptors as well as DNA encoding for such polypeptides; receptor binding assays; drug screening; obesity; prolactin production inhibitors |
| 07/14/2005 | US20050153376 Superantigens |
| 07/14/2005 | US20050153375 CEA/NCA-based differentiation cancer therapy |
| 07/14/2005 | US20050153374 Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposes |
| 07/14/2005 | US20050153373 Isolated from Bacillus substilis; multimeric polypeptide antigens; antibodies; solid phase synthesis; reverse transcription; kits; immunohistochemistry |
| 07/14/2005 | US20050153369 Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX |
| 07/14/2005 | US20050153368 Using dipteran neuronal cells to identify components of human sweat which modulate activities of mosquito odorant receptor; mosquito repellant; biological pest control |
| 07/14/2005 | US20050153352 Using oncogenic protein (MG20) as tool in identifying modulators for diagnosis prevention and treatment of cell proliferative disorders |
| 07/14/2005 | US20050153348 Using membrane protein expression pattern as diagnostic and prognostic tool in detection of breast, colon and lung tissue cell proliferative disorders |
| 07/14/2005 | US20050153335 Expression vector comprising nucleotide sequences coding membrane protein for use in identifying modulator for prevention and treatmment of cell proliferative, inflammatory and nervous system disorders |
| 07/14/2005 | US20050153334 Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
| 07/14/2005 | US20050153330 Novel DKR polypeptides |
| 07/14/2005 | US20050153327 Human ataxin-1-like polypeptide IMX97018 |
| 07/14/2005 | US20050153325 Using fibroblast growth factor receptor activating gene 1 (FRAG1) probe as diagnostic tool in detection and classification of tumor disorders |
| 07/14/2005 | US20050153322 Administering to the mammal a polypeptide for stimulating gastrointestinal contractility in a mammal |
| 07/14/2005 | US20050153313 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 07/14/2005 | US20050153307 PNA oligomers, oligomer sets, methods and kits pertaining to the determination of Enterococcus faecalis and other Enterococcus species |
| 07/14/2005 | US20050153306 Libraries; peptide nucleic acids; for assaying hydrolases/proteases |
| 07/14/2005 | US20050153305 Novel proteins and nucleic acids encoding same |
| 07/14/2005 | US20050153301 Reproduction regulator enriched in the pituitary of E.coioides and use thereof |
| 07/14/2005 | US20050153295 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases |
| 07/14/2005 | US20050153289 Method of analyzing gene expression |
| 07/14/2005 | US20050153288 Methods for identifying gibberellin responsive genes using cultured vegetable cells |
| 07/14/2005 | US20050153287 Nr3b nmda receptor subunit compositions and related methods |
| 07/14/2005 | US20050153286 Calcium channel polypeptide for use in identifying modulator for prevention and treatment of cell proliferative disorders of the kidney |
| 07/14/2005 | US20050153279 Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 07/14/2005 | US20050152985 The use of Colostrinin as a medicament, particularly in the treatment of chronic disorders of the central nervous system and the immune system. |
| 07/14/2005 | US20050152984 Membrane scaffold proteins |
| 07/14/2005 | US20050152959 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell |
| 07/14/2005 | US20050152927 Allergenic proteins and peptides from Japanese cedar pollen |
| 07/14/2005 | US20050152926 For immunization and/or diagnosis; eg pneumonia, cardiovascular diseases, atherosclerosis, bronchitis |
| 07/14/2005 | US20050152920 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof |
| 07/14/2005 | US20050152917 Fusion protein for use in the treatment of viral diseases |
| 07/14/2005 | US20050152916 Antigen presenting system and methods for activation of T-cells |
| 07/14/2005 | US20050152911 Norovirus monoclonal antibodies and peptides |
| 07/14/2005 | US20050152909 Prostate stem cell antigen (PSCA) tumor antigen for use in diagnosis, prevention and treatment of prostate cancers |
| 07/14/2005 | US20050152908 Expressed in blood and useful in diagnosing liver cancer as well as monitoring therapeutic efficacy; polynucleotides; eg amyloid beta (A4) precursor-like protein 2 (APLP2); BCL2-related protein A1 (BCL2A1) |
| 07/14/2005 | US20050152904 Novel P-selectin glycoprotein ligand (PSGL-1) binding protein and uses therefor |
| 07/14/2005 | US20050152903 antibodies or FAB fragments that specifically binds to high mobility group box (HMGB) proteins but does not specifically bind to non-A box epitopes of HMGB; inhibiting release of proinflammatory cytokine from from a vertebrate cell treated with high mobility group protein |
| 07/14/2005 | US20050152900 Compositions and methods for apo-b48 and apo-b100 assay |
| 07/14/2005 | US20050152897 Methods for inducing T cell tolerance to a tissue or organ graft |
| 07/14/2005 | US20050152883 isolation of ligament cells, then culturing, recovering and implanting the cells into patients |
| 07/14/2005 | US20050152878 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 07/14/2005 | US20050152872 Fusion constructs cotaining active sections of tnf ligands |
| 07/14/2005 | US20050152871 treating the subject in need with one or more chemokines and/or a DNA damaging agent inducing said chemokine(s); |
| 07/14/2005 | US20050152853 Signal peptides, nucleic acid molecules and methods for treatment of caries |
| 07/14/2005 | US20050152848 covalently coupling insulin to one or more molecules of a non-naturally occurring hydrophilic polymer such as polyethylene glycol; antidiabetic agents |
| 07/14/2005 | US20050150769 Method of separating biocomponents contained in a liquid, a separating system and a separating unit |
| 07/14/2005 | CA2804953A1 Plant activation of insect toxin |
| 07/14/2005 | CA2552155A1 Use of il-18 binding protein in inflammations |
| 07/14/2005 | CA2552150A1 Means for stimulation and activation of hair growth by il-15 |
| 07/14/2005 | CA2551916A1 Fc-erythropoietin fusion protein with improved pharmacokinetics |
| 07/14/2005 | CA2551915A1 Il-7 fusion proteins |
| 07/14/2005 | CA2551813A1 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 07/14/2005 | CA2551612A1 Process for purification of hemoglobin |
| 07/14/2005 | CA2551094A1 Methods and compositions for identifying rna-binding proteins |